Back

Increased bleeding risk in cancer patients with atrial fibrillation. Can we identify risk predictors?

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Comorbidities and mortalities Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Ana Pardo Sanz

Ramon and Cajal University Hospital, Madrid (Spain)

10 More presentations in this session

Presentation thumbnail
Cancer and risk of atrial fibrillation: a systematic review and meta-analysis.
Doctor T. Liu (Tianjin, CN)
Abstract
Presentation thumbnail
Mortality and atrial fibrillation in the FIACA study: evidence of a differential effect according to the diagnosis of hospital admission.
Doctor D. Fernandez-Berges (Villanueva de la Serena, ES)
Abstract Slides
Presentation thumbnail
Multimorbidity and comorbidity in atrial fibrillation and effects on survival: findings from UK biobank cohort
Professor D. Connelly (Glasgow, GB)
Abstract
Presentation thumbnail
Patients with cancer and atrial fibrillation treated with NOACs: data from a prospective cohort
Doctor M. Vedovati (Perugia, IT)
Abstract Slides
Presentation thumbnail
Comorbid malignancy as an independent predictor of in-hospital mortality in patients with atrial fibrillation.
Doctor K. Voudris (Chicago, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Comorbidities and mortalities

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources